首页>
外国专利>
CEPHALOSPORIN AND PENICILLIN ANTIBIOTICS
CEPHALOSPORIN AND PENICILLIN ANTIBIOTICS
展开▼
机译:头孢菌素和青霉素类抗生素
展开▼
页面导航
摘要
著录项
相似文献
摘要
1490451 Cephalosporin and penicillin derivatives YEDA RESEARCH & DEVELOPMENT CO Ltd 13 June 1975 [24 June 1974] 25460/75 Heading C2C Novel compounds I (either Aryl is a benzene ring; Y is H, Cl, Br, 1-4 C alkyl or 1-4 C-n-alkoxy and Z is a bond, S, O, or NH; or Aryl is a thiophen ring attached to Z by its 2-position; Y is H and Z is a bond; W is H, CH 3 , NH 2 , OH, SO 3 H or COORSP4/SP where RSP4/SP is H or 5-indanyl; RSP1/SP, RSP2/SP and RSP3/SP are H or 1-4 C alkyl; n is 0, 1 or 2 provided it is not 0 when W is not H or CH 3 and Z is not a bond; RSP5/SP is H or OCH 3 ; and RSP6/SP is of Formula II or III where M is H, cation, -CH 2 OCORSP7/SP, -CH 2 N(RSP9/SP)CORSP8/SP, p-(RSP10/SPCOO) benzyl, -CH 2 O-CO-(CH 2 ) m -C(RSP11/SP)(RSP12/SP)-NRSP13/SPRSP14/SP; RSP7/SP is 1-4 C alkyl; RSP8/SP is 1-4 C alkyl or alkoxy; RSP9/SP is H or 1-4 C alkyl; RSP10/SP is 1-4 C alkyl; m is 0-5; RSP11/SP and RSP12/SP are H or 1-4 C alkyl; RSP13/SP and RSP14/SP are H or 1-4 C alkyl and X is H, OCOCH 3 , 1,3,4-thiadiazol-5-ylthio, 3-methyl- 1,2,4 - thiadiazol - 5 - ylthio, tetrazol - 5 - ylthio, 1 - methyltetrazol - 5 - ylthio, 2 - methyl- 1,3,4 - oxadiazol - 5 - ylthio, or 2 - methyl- 1,3,4 - thiadiazol - 5 - ylthio) are prepared by reaction of a compound IV with a compound V or by reaction of a compound VI with a compound VII or a functional derivative thereof (WSP2/SP is as W above); or by other conventional procedures. Compounds IV may be prepared by reaction of a compound VI with an acid VIII Compounds VIII may be prepared by halomethylation of a compound IX The preparation of numerous starting materials is also described in the examples. Pharmaceutical compositions, useful as antibiotics, comprise a compound I together with a suitable diluent or carrier.
展开▼
机译:1490451头孢菌素和青霉素衍生物YEDA RESEARCH&DEVELOPMENT CO Ltd 1975年6月13日[1974年6月24日]标题C2C新化合物I(芳基为苯环; Y为H,Cl,Br,1-4 C烷基或1 -4 Cn烷氧基,Z为键,S,O或NH;或芳基为噻吩环,通过其2-位与Z相连; Y为H,Z为键; W为H,CH 3,NH 2,OH,SO 3 H或COOR 4 SP>,其中R 4 SP>是H或5-茚满; R 1 SP>,R 2 < / SP>和R 3 SP>为H或1-4个碳原子的烷基; n为0、1或2,如果W不是H或CH 3并且Z不是键,则n不为0; R 5 SP>为H或OCH 3; R 6 SP>为式II或III,其中M为H,阳离子,-CH 2 OCOR 7 SP>, -CH 2 N(R 9 SP>)COR 8 SP>,对-(R 10 SP> COO)苄基,-CH 2 O-CO-(CH 2)m -C(R 11 SP>)(R 12 SP>)-NR 13 SP> R 14 SP>; R 7 SP>是1-4 C烷基; R 8 SP>是1-4 C烷基或烷氧基; R 9 SP>是H或1-4 C烷基; R 10 SP>是1-4个碳原子的烷基; m是0-5; R 11 SP>和R 12 SP> ar H或1-4个碳的烷基; R 13 SP>和R 14 SP>是H或1-4 C烷基,X是H,OCOCH 3,1,3,4-噻二唑-5-基硫基,3-甲基-1,2,4-噻二唑-5-乙硫基,四唑-5-乙硫基,1-甲基四唑-5-乙硫基,2-甲基-1,3,4-恶二唑-5-乙硫基或2-甲基-1通过化合物IV与化合物V反应或通过化合物VI与化合物VII或其功能衍生物(W 2 SP> W以上);或通过其他常规程序。化合物Ⅳ可以通过化合物Ⅵ与酸的反应来制备。化合物可以通过化合物ha的卤甲基化来制备。在实施例中还描述了许多原料的制备。用作抗生素的药物组合物包含化合物I以及合适的稀释剂或载体。
展开▼